New Vein Foam Performs Well In U.S. Trials

Last fall, we told you about the positive results of foam injections for collapsing varicose veins based on research by Imperial College London. People who were treated with the foam recovered faster using the less-expensive foam when compared to laser treatments. Now, a British foam has performed well in its second round of U.S. clinical trials.

During the procedure, the foam Varisolve is injected into a bulging surface-level vein, causing it to eventually collapse. The manufacturer, British pharmaceutical company BTG, said it expects to have an 80 percent success rate according to a FoxNews report. Concerns of the agent getting in the blood stream stopped the U.S. drug trial nine years ago, but BTG states that the 590 patients in the trial had no significant safety concerns during the recent studies.

The analysis of the risk versus benefits will surely be examined closely before the FDA decides to green light this new medication. Meanwhile, many other injectables are currently used to treat varicose veins, as well as laser treatments. We'll keep you updated on all the latest options.


Related Links:
What to Do About Those Spider Veins
Can Varicose Veins Be Prevented?

Find Vein Treatments Doctors near you: